Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - April 19.12.2025 FAPR.LN IE000WX2HZQ7 150,002.00 USD 3,646,124.46 24.307 ...
-
‘Food for Health’ Ho, Ho, Hosts Holiday Party and Food Pantry in Westlake
LOS ANGELES--(BUSINESS WIRE)--‘Food for Health’ Ho, Ho, Hosts Holiday Party and Food Pantry in Westlake...
-
Ocean Park Named 2025 ThinkAdvisor Luminaries Award Winner
LOS ANGELES--(BUSINESS WIRE)--Ocean Park Asset Management's “Duck” campaign has been named the winner of the 2025 ThinkAdvisor Luminaries Award for Excellence in Marketing & PR....
-
IMAX Soars to Top Five All-Time Global Opening with $43.6 Million Debut of James Cameron’s “Avatar: Fire and Ash”
NEW YORK--(BUSINESS WIRE)--IMAX Corporation (NYSE: IMAX) soared to a $43.6 million global opening weekend with Disney/20th Century Studios’ “Avatar: Fire and Ash” — delivering the Company’s biggest opening weekend of 2025 and the fifth biggest debut in IMAX history. Building on the record-breaking bond between James Cameron’s groundbreaking sci-fi saga and IMAX, fans turned out to experience the highly anticipated threequel in IMAX in outsized numbers; IMAX delivered 12.6% of the global debut o...
-
Lumen Technologies, Inc. Announces Early Results and Amendments of Previously Announced Tender Offers and Consent Solicitations
DENVER--(BUSINESS WIRE)--Lumen Technologies, Inc. (“Lumen,” “us,” “we” or “our”) (NYSE: LUMN) today announced the early results of the previously announced cash tender offers (each, a “Tender Offer” and collectively, the “Tender Offers”) by its wholly-owned subsidiary, Level 3 Financing, Inc. (“Level 3 Financing”) to purchase the outstanding notes described below, in each case subject to certain terms and conditions set forth in the Offers to Purchase and Solicitations of Consents dated Decembe...
-
Fiserv Collaborates with Visa to Accelerate Agentic Commerce
MILWAUKEE--(BUSINESS WIRE)--Fiserv, Inc. (NASDAQ: FISV) today announced a strategic collaboration with Visa (NYSE: V) to enable Visa Intelligent Commerce and deploy Trusted Agent Protocol across Fiserv’s interoperable agentic ecosystem. This will empower merchants to participate in the rapidly evolving world of Agentic Commerce, where artificial intelligence-driven agents act on behalf of consumers to discover, compare, and purchase products. By combining Visa’s authentication and agentic comme...
-
DISCO Appoints Aaron Barfoot as Chief Financial Officer
AUSTIN, Texas--(BUSINESS WIRE)--DISCO (NYSE: LAW), a creator of industry-leading litigation technology, today announced that enterprise SaaS, artificial intelligence and digital security veteran Aaron Barfoot has been appointed chief financial officer, effective January 12, 2026. “Aaron’s impressive background in scaled software and AI in high-growth industries and significant experience leading major finance disciplines at public companies make him a great fit for DISCO as we continue to focus...
-
StubHub App Launches in OpenAI ChatGPT – One of the First Ticketing Platforms to Offer Discovery Experience
NEW YORK--(BUSINESS WIRE)--StubHub, the world's leading live event marketplace, today announced it is one of the first ticketing platforms to launch an app on ChatGPT with a discovery experience. The integration transforms how fans find live events—replacing tab-switching and manual filtering with a conversational assistant that understands what you're actually looking for. Ask ChatGPT to "Find me Yankee games next weekend" —and StubHub's app delivers real-time options you can refine naturally....
-
Savara Resubmits the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced today that it has resubmitted the MOLBREEVI BLA to the FDA, with Fujifilm as the drug substance manufacturer. The MOLBREEVI BLA submission is seeking approval for the treatment of autoimmune PAP, a chronic and debilitating rare lung disease characterized by the abnormal build-up of surfactant in the alveoli. The Company has request...
-
Amprius Technologies Announces CEO Transition
FREMONT, Calif.--(BUSINESS WIRE)--Amprius Technologies, Inc. (“Amprius” or the “Company”) (NYSE: AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced that its Board of Directors (the “Board”) has appointed President Tom Stepien as its next Chief Executive Officer (“CEO”), effective January 1, 2026. Current Amprius CEO Dr. Kang Sun will be retiring at the end of 2025. Dr. Sun will continue to serve as a director on the Board and as an Executiv...